Search

everythinglearnresearchcommunity

for

Search:↓

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Analog 23 is a promising compound for prostate cancer treatment.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

New treatments for male hypogonadism are effective and should be personalized.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Antiandrogens block male hormones and are not safe during pregnancy.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Androgens can both increase body hair and cause scalp hair loss.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

PRP treatment helps hair growth and density in androgenetic alopecia patients.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Red and infrared light therapy improves hair growth in balding patients.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Cyclosporin doesn't stop hair loss.

Hair from balding and non-balding areas regrows similarly on mice.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.